Telix Pharmaceuticals | TLX - Zahlungsmittel Und Äquivalente

Aktienkurs
14.55
Täglich Wechseln
0.91 6.67%
Monatlich
35.22%
Jährlich
-44.44%
Q2 Prognose
12.67




Zahlungsmittel Und Äquivalente Veränderung Datum
Cochlear AUD 275.7M 107.4M 2025-06
CSL USD 2.16B 633M 2025-06
Integral Diagnostics AUD 17.99M 15.86M 2023-12
Mayne Pharma AUD 110.07M 838K 2024-06
Medical Developments International AUD 17.84M 219K 2025-06
Mesoblast USD 129.57M 31.58M 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Pacific Edge NZD 29.26M 8.79M 2024-06
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
Polynovo AUD 29.21M 16.7M 2025-12
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Ramsay Health Care AUD 784.4M 443.3M 2025-06
ResMed USD 1.42B 33.22M 2025-12
Sonic Healthcare AUD 645M 25.39M 2024-06